Toll-like receptor 4 expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis

• Published in: BMC Immunology 2011, Vol.12, p.18
• Main Authors: Garay-Malpartida, Humberto M, Mourão, Roberta F, Mantovani, Marluce, Santos, Icaro A, Sogayar, Mari C, Goldberg, Anna C
• Format: Report
• Language: English
• Subjects: Insulin; Islet cell transplantation; Pancreatic beta cells; Patient outcomes; Physiological aspects; TLR4
• ISSN: 1471-2172; 1471-2172
• DOI: 10.1186/1471-2172-12-18

Toll-like receptor 4 (TLR4) is widely recognized as an essential element in the triggering of innate immunity, binding pathogen-associated molecules such as Lipopolysaccharide (LPS), and in initiating a cascade of pro-inflammatory events. Evidence for TLR4 expression in non-immune cells, including pancreatic [beta]-cells, has been shown, but, the functional role of TLR4 in the physiology of human pancreatic [beta]-cells is still to be clearly established. We investigated whether TLR4 is present in [beta]-cells purified from freshly isolated human islets and confirmed the results using MIN6 mouse insulinoma cells, by analyzing the effects of TLR4 expression on cell viability and insulin homeostasis. CD11b positive macrophages were practically absent from isolated human islets obtained from non-diabetic brain-dead donors, and TLR4 mRNA and cell surface expression were restricted to [beta]-cells. A significant loss of cell viability was observed in these [beta]-cells indicating a possible relationship with TLR4 expression. Monitoring gene expression in [beta]-cells exposed for 48h to the prototypical TLR4 ligand LPS showed a concentration-dependent increase in TLR4 and CD14 transcripts and decreased insulin content and secretion. TLR4-positive MIN6 cells were also LPS-responsive, increasing TLR4 and CD14 mRNA levels and decreasing cell viability and insulin content. Taken together, our data indicate a novel function for TLR4 as a molecule capable of altering homeostasis of pancreatic [beta]-cells.